ArticleJournal of pharmaceutical analysis2025
DTLCDR: A target-based multimodal fusion deep learning framework for cancer drug response prediction.
Jie Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it